LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 723

Search options

  1. Article: [Clinical application and standardized implementation of intersphincteric resection].

    Chi, P / Wang, X J

    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

    2023  Volume 26, Issue 6, Page(s) 548–556

    Abstract: Intersphincteric resection (ISR) is the ultimate sphincter-preserving surgical technique for low rectal cancer. To promote the standardized implementation of ISR, this review discusses the important issues regarding the clinical application of ISR with ... ...

    Abstract Intersphincteric resection (ISR) is the ultimate sphincter-preserving surgical technique for low rectal cancer. To promote the standardized implementation of ISR, this review discusses the important issues regarding the clinical application of ISR with reference to the latest Chinese expert consensus on ISR. In terms of ISR-related pelvic anatomy of the rectum/anal canal, hiatal ligament is not identical with the anococcygeal ligament. At the level where the rectourethralis muscle continuously extends to the posteroinferior area of the membranous urethra from the rectum, the neurovascular bundle is identified between the posterior edge of rectourethralis muscle and the anterior edge of the longitudinal muscle of the rectum. This knowledge is crucial to detect the anterior dissection plane during ISR at the levator hiatus level. The indication criteria for ISR included: (1) stage I early low rectal cancer; (2) stage II-III low rectal cancer undergoing neoadjuvant treatment, and supra-anal tumors and juxta-anal tumors of stage ycT3NxM0, or intra-anal tumors of stage ycT2NxM0. However, signet ring cell carcinoma, mucinous adenocarcinoma and undifferentiated carcinoma should be contraindicated to ISR. For locally advanced low rectal cancer (especially anteriorly located tumor), neoadjuvant treatment should be carried out in a standardized manner. However, it should be recognized that neoadjuvant chemoradiotherapy was a risk factor for poor anal function after ISR. For surgical approaches for ISR, including transanal, transabdominal, and transanal transabdominal approaches, the choice should be based on oncological safety and functional consequences. While ensuring the negative margin, maximal preservation of rectal walls and anal canal contributs to better postoperative anorectal function. Careful attention must be paid to complications regarding ISR, with special focus on the anastomotic complications. The incidence of low anterior resection syndrome (LARS) was higher than 40%. However, this issue is often neglected by clinicians. Thus, management and rehabilitation strategies for LARS with longer follow-ups were required.
    MeSH term(s) Humans ; Rectal Neoplasms/surgery ; Rectal Neoplasms/pathology ; Postoperative Complications ; Laparoscopy/methods ; Anal Canal/surgery ; Anal Canal/pathology ; Anus Neoplasms/pathology ; Anus Diseases/surgery ; Low Anterior Resection Syndrome ; Carcinoma, Signet Ring Cell/pathology ; Treatment Outcome
    Language Chinese
    Publishing date 2023-08-15
    Publishing country China
    Document type Review ; English Abstract ; Journal Article
    ISSN 1671-0274
    ISSN 1671-0274
    DOI 10.3760/cma.j.cn441530-20230228-00056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: [Historical evolution and ultimate goal of minimally invasive surgery for colorectal cancer].

    Chi, P / Wang, X J

    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

    2022  Volume 25, Issue 8, Page(s) 675–681

    Abstract: Minimally invasive colorectal surgery has been an entity for just over 30 years. Compared with traditional open surgery, minimally invasive surgery has the advantages of less trauma, more delicate operation and faster postoperative recovery. At present, ... ...

    Abstract Minimally invasive colorectal surgery has been an entity for just over 30 years. Compared with traditional open surgery, minimally invasive surgery has the advantages of less trauma, more delicate operation and faster postoperative recovery. At present, minimally invasive surgery for colorectal tumor shows a diversified trend in terms of surgical approach, surgical platform or surgical methods. Besides, standardized comprehensive treatment and immunotherapy have had far-reaching impacts on the development of minimally invasive surgery. The diagnosis and treatment of perioperative complications is still another important topic in the research of minimally invasive surgery in the future. In addition to the short-term outcomes, the most important thing that patients truly require and emphasize is the permanence of the curative effect, that is, long-term survival and good defecation, urination and sexual function. Thus, permanence is the ultimate goal of minimally invasive surgery. To achieve this, we should strive to correct improper treatment methods, rationally select applicable groups of emerging surgical approaches and surgical platforms, pay more attention to comprehensive tumor diagnosis and treatment, and prudently carry out new technology research on the basis of the basic concept of patient safety.
    MeSH term(s) Colorectal Neoplasms/pathology ; Colorectal Neoplasms/surgery ; Goals ; Humans ; Laparoscopy ; Minimally Invasive Surgical Procedures ; Postoperative Period
    Language Chinese
    Publishing date 2022-05-26
    Publishing country China
    Document type Journal Article
    ISSN 1671-0274
    ISSN 1671-0274
    DOI 10.3760/cma.j.cn441530-20220426-00182
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: [Expert consensus on endocrine therapy of breast cancer (2023 edition)].

    Zhang, S H / Wang, X J / Jiang, Z F

    Zhonghua yi xue za zhi

    2023  Volume 103, Issue 38, Page(s) 2993–3001

    Abstract: Endocrine therapy is the primary systemic therapy for hormone receptor-positive breast cancer, which runs through the whole process of treatment for early and metastatic breast cancer. The development of new endocrine agents and targeted drugs such as ... ...

    Abstract Endocrine therapy is the primary systemic therapy for hormone receptor-positive breast cancer, which runs through the whole process of treatment for early and metastatic breast cancer. The development of new endocrine agents and targeted drugs such as cyclin-dependent kinases 4/6(CDK4/6)inhibitors has improved outcome of patients with hormone receptor-positive breast cancer and changed the treatment landscape. The update of clinical research data provides more treatment options, calling for treatment optimization. Experts had a deep discussion around the hot topics on endocrine therapy of breast cancer, and formulated the'Expert consensus on endocrine therapy of breast cancer (2023 edition)'.This consensus is based on research data worldwide and clinical practice experience, with the aims of standardizing clinical diagnosis and optimizing treatment in neoadjuvant, adjuvant and metastatic setting of hormone receptor-positive breast cancer.
    MeSH term(s) Humans ; Female ; Breast Neoplasms/drug therapy ; Consensus ; Neoadjuvant Therapy ; Cyclin-Dependent Kinase 4/therapeutic use ; Receptor, ErbB-2/therapeutic use ; Cyclin-Dependent Kinase 6/therapeutic use ; Protein Kinase Inhibitors/therapeutic use
    Chemical Substances Cyclin-Dependent Kinase 4 (EC 2.7.11.22) ; Receptor, ErbB-2 (EC 2.7.10.1) ; Cyclin-Dependent Kinase 6 (EC 2.7.11.22) ; Protein Kinase Inhibitors
    Language Chinese
    Publishing date 2023-08-18
    Publishing country China
    Document type English Abstract ; Journal Article
    ZDB-ID 132513-9
    ISSN 0376-2491
    ISSN 0376-2491
    DOI 10.3760/cma.j.cn112137-20230616-01027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: [Significance of the intact of the fascia propria in protection of pelvic plexus during total mesorectal excision].

    Chi, P / Wang, X J

    Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

    2021  Volume 24, Issue 4, Page(s) 297–300

    Abstract: Total mesorectal excision (TME) is the gold standard of surgical treatment for mid and low rectal cancer. It aims to improve the oncological outcomes as well as preserve anal sphincter, sexual and urinary function. Compared with sympathetic nerve injury ... ...

    Abstract Total mesorectal excision (TME) is the gold standard of surgical treatment for mid and low rectal cancer. It aims to improve the oncological outcomes as well as preserve anal sphincter, sexual and urinary function. Compared with sympathetic nerve injury alone, pelvic plexus and neurovascular bundle (NVB) injury has significant effect on postoperative sexual dysfunction, especially erectile function. Since the lateral surgical plane of TME is narrow and densely packed, dissecting outside the plane causes pelvic plexus injury, while dissecting inside it results in residual mesorectum. In this commentary, we review the research progress of lateral fascial anatomy of TME, and describe the anatomical characteristics of rectosacral fascia based on our previous research results. The prehypogastric fascia acts as a "fascia barrier" when dissecting the lateral space constantly from posterior to anterior. In addition, the pelvic plexus fuses with the prehypogastric fascia which is considered as the outer side layer of rectosacral fascia laterally. Thus, the rectosacral fascia should be dissected at the level of S4 vertebral body posterior to the rectum in an arc shape and then enter the superior-levator space. Before dissecting the lateral spaces, the anterior space of the rectum should be dissected first. After an "U" shape cutting of the Denonvilliers' fascia, the lateral space should be dissected from anterior to posterior. Finally, the lateral attachment of rectosacral fascia is transected to ensure the integrity of the mesorectum without damaging the pelvic plexus.
    MeSH term(s) Fascia ; Humans ; Hypogastric Plexus ; Laparoscopy ; Male ; Pelvis/surgery ; Rectal Neoplasms/surgery ; Rectum/surgery
    Language Chinese
    Publishing date 2021-04-05
    Publishing country China
    Document type Journal Article ; Review
    ISSN 1671-0274
    ISSN 1671-0274
    DOI 10.3760/cma.j.cn.441530-20210121-00035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: [Common drugs that cause abnormalities in the thyroid gland functions and their impact on levels of serum biomarkers].

    Jin, Z Z / Wang, X J

    Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine

    2021  Volume 55, Issue 6, Page(s) 797–803

    Abstract: The abnormal thyroid function in the duration of drug treatment has attracted increasing attention, these drugs included traditional drugs, such as glucocorticoid, nonsteroidal anti-inflammatory drug, iodine agent, etc.; also included new types of drugs, ...

    Abstract The abnormal thyroid function in the duration of drug treatment has attracted increasing attention, these drugs included traditional drugs, such as glucocorticoid, nonsteroidal anti-inflammatory drug, iodine agent, etc.; also included new types of drugs, such as immune checkpoint inhibitors. The possible reasons causing abnormality of thyroid biomarkers included drugs' toxicity on thyroid, drug-drug interaction affecting synthetic thyroid hormones therapy, and drug's interference on biomarkers' measurement. This article focused on the influence and mechanisms of common drugs on the regulation, synthesis, release, transport and metabolism of thyroid hormones. Here also briefly introduced the mechanism of drug-drugs interaction on the effect of synthetic thyroid hormone; the interference and mechanism of some drugs on the laboratory measurement was also included. The aim of this article was to strengthen clinician's understanding on drug-induced thyroid diseases and to be alert to drugs' interference on the in-vitro measurement of biomarkers.
    MeSH term(s) Biomarkers ; Humans ; Iodine ; Pharmaceutical Preparations ; Thyroid Diseases/chemically induced ; Thyroid Hormones
    Chemical Substances Biomarkers ; Pharmaceutical Preparations ; Thyroid Hormones ; Iodine (9679TC07X4)
    Language Chinese
    Publishing date 2021-06-14
    Publishing country China
    Document type Journal Article
    ZDB-ID 604575-3
    ISSN 0253-9624
    ISSN 0253-9624
    DOI 10.3760/cma.j.cn112150-20210209-00143
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: [A new understanding of wound repair after surgery for benign prostatic hyperplasia].

    Qian, Y X / Liu, S Y / Wang, X J / Xia, S J

    Zhonghua yi xue za zhi

    2023  Volume 103, Issue 16, Page(s) 1163–1167

    Abstract: Benign prostatic hyperplasia (BPH) is one of the most common diseases in elderly men. Transurethral resection of prostate (TURP), as an important BPH treatment, is also the most effective way to relieve prostatic obstruction. However, postoperative ... ...

    Abstract Benign prostatic hyperplasia (BPH) is one of the most common diseases in elderly men. Transurethral resection of prostate (TURP), as an important BPH treatment, is also the most effective way to relieve prostatic obstruction. However, postoperative complications, such as lower urinary tract symptoms (LUTS), infection, hematuria and bladder neck contracture, may still occur, which seriously impact the therapeutic effect and patients' quality of life. The wound healing after BPH surgery is closely associated with the occurrence of postoperative complications. Therefore, comprehensively understanding the influencing factors of wound healing and designing tailored interventions will be particularly important for reducing postoperative complications of BPH.
    MeSH term(s) Male ; Humans ; Aged ; Prostatic Hyperplasia/complications ; Transurethral Resection of Prostate ; Quality of Life ; Postoperative Complications ; Wound Healing ; Treatment Outcome
    Language Chinese
    Publishing date 2023-04-07
    Publishing country China
    Document type English Abstract ; Journal Article
    ZDB-ID 132513-9
    ISSN 0376-2491
    ISSN 0376-2491
    DOI 10.3760/cma.j.cn112137-20221213-02636
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Clinical efficacy of enhanced external counter pulsation plus sacubitril/valsartan in the treatment of patients with chronic heart failure and the effect on ankle-arm index and cardiac function.

    Huang, X-L / Wang, X-J / Chen, B-T / Chen, Y-N

    European review for medical and pharmacological sciences

    2023  Volume 27, Issue 8, Page(s) 3300–3312

    Abstract: Objective: The aim of this study was to evaluate the clinical efficacy of enhanced external counter pulsation (EECP) plus sacubitril/valsartan in the treatment of patients with chronic heart failure (CHF) and the effect on ankle-arm index and cardiac ... ...

    Abstract Objective: The aim of this study was to evaluate the clinical efficacy of enhanced external counter pulsation (EECP) plus sacubitril/valsartan in the treatment of patients with chronic heart failure (CHF) and the effect on ankle-arm index and cardiac function.
    Patients and methods: In this retrospective study, 106 patients with chronic heart failure treated in our hospital from September 2020 to April 2022 were recruited and randomly assigned to receive either sacubitril/valsartan (observation group) or EECP plus sacubitril/valsartan (combination group) alternately at the point of admission, with 53 patients in each group. Outcome measures included clinical efficacy, ankle brachial index (ABI), cardiac function indices [N-terminal brain natriuretic peptide precursor (NT-proBNP), 6 min walking distance (6MWD), left ventricular ejection fraction (LVEF)], and adverse events.
    Results: EECP plus sacubitril/valsartan resulted in significantly higher treatment efficiency and ABI levels vs. sacubitril/valsartan (p<0.05). Patients receiving combined therapy showed significantly lower NT-proBNP levels than those given monotherapy (p<0.05). EECP plus sacubitril/valsartan resulted in longer 6MWD and higher LVEF than sacubitril/valsartan alone (p<0.05). No significant differences were observed in the adverse events between the two groups (p>0.05).
    Conclusions: EECP plus sacubitril/valsartan substantially improves the ABI levels, cardiac functions, and exercise tolerance of patients with chronic heart failure, with a high safety profile. EECP improves blood supply to myocardial ischemic tissues by increasing ventricular diastolic blood return and blood perfusion to ischemic myocardium, raises aortic diastolic pressure, restores pumping function, improves LVEF, and reduces NT-proBNP secretion.
    MeSH term(s) Humans ; Stroke Volume ; Retrospective Studies ; Ankle Brachial Index ; Ankle ; Tetrazoles/therapeutic use ; Ventricular Function, Left ; Valsartan/therapeutic use ; Heart Failure ; Biphenyl Compounds/therapeutic use ; Drug Combinations ; Treatment Outcome ; Angiotensin Receptor Antagonists/therapeutic use
    Chemical Substances sacubitril (17ERJ0MKGI) ; Tetrazoles ; Valsartan (80M03YXJ7I) ; Biphenyl Compounds ; Drug Combinations ; Angiotensin Receptor Antagonists
    Language English
    Publishing date 2023-05-05
    Publishing country Italy
    Document type Journal Article ; Comment
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_202304_32101
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: [Plasmablastic plasma cell myeloma: report of a case].

    Mo, J N / Wang, X J / Liu, X Y

    Zhonghua bing li xue za zhi = Chinese journal of pathology

    2022  Volume 51, Issue 3, Page(s) 247–249

    MeSH term(s) Diagnosis, Differential ; Humans ; Multiple Myeloma ; Plasma Cells
    Language Chinese
    Publishing date 2022-03-05
    Publishing country China
    Document type Case Reports ; Journal Article
    ZDB-ID 784533-9
    ISSN 0529-5807
    ISSN 0529-5807
    DOI 10.3760/cma.j.cn112151-20210808-00557
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: [The review of atrioventricular node ablation combined with His-Purkinje conduction system pacing in the treatment of atrial fibrillation and heart failure].

    Wang, X J / Dong, Y X / Xia, Y L

    Zhonghua xin xue guan bing za zhi

    2022  Volume 50, Issue 9, Page(s) 938–942

    MeSH term(s) Atrial Fibrillation/surgery ; Atrioventricular Node/surgery ; Catheter Ablation ; Heart Failure/therapy ; Humans
    Language Chinese
    Publishing date 2022-06-15
    Publishing country China
    Document type Journal Article
    ZDB-ID 603425-1
    ISSN 0253-3758
    ISSN 0253-3758
    DOI 10.3760/cma.j.cn112148-20220726-00580
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: ATP2B1 gene rs71454161, rs73196661 and rs73196675 polymorphisms in eclampsia.

    Zhou, Z-Y / Wang, X-J / Chen, G-Z

    European review for medical and pharmacological sciences

    2022  Volume 26, Issue 4, Page(s) 1255–1262

    Abstract: Objective: We aimed to explore the associations of the ATP2B1 gene polymorphisms with eclampsia.: Patients and methods: A total of 150 patients with eclampsia (disease group) and 150 healthy pregnant women (control group) were taken as the subjects ... ...

    Abstract Objective: We aimed to explore the associations of the ATP2B1 gene polymorphisms with eclampsia.
    Patients and methods: A total of 150 patients with eclampsia (disease group) and 150 healthy pregnant women (control group) were taken as the subjects of study. The peripheral blood of the two groups of subjects was collected to extract deoxyribonucleic acids (DNAs), and the ATP2B1 gene rs71454161, rs73196661 and rs73196675 polymorphisms were detected by sequencing the Polymerase Chain Reaction (PCR) products, and then, analyzed combined with gene expression determined via Reverse Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) and clinical indicators, such as 24-h urine protein, platelets, and LDH.
    Results: A difference was observed in the allele distribution of ATP2B1 gene rs71454161 (p=0.000) and rs73196661 (p=0.011) between the disease group and control group. Disease group exhibited higher frequencies of allele G of rs71454161 and allele T of rs73196661 than control group. Besides, there was a difference in the genotype distribution of ATP2B1 gene rs71454161 (p=0.000), rs73196661 (p=0.000) and rs73196675 (p=0.000) between disease group and control group. Disease group exhibited higher frequencies of genotype GG of rs71454161, genotype TT of rs73196661 and genotype CG of rs73196675 than control group. Moreover, a difference in the distributions of ATP2B1 gene rs71454161 (p=0.000) and rs73196661 (p=0.014) was found between the two groups in the dominant model. Disease group exhibited lower frequencies of AA+AG of rs71454161 and CC+CT of rs73196661 than control group in the dominant model. Differences in the distributions of haplotypes ACC (p=0.000), ATC (p=0.047) and GTC (p=0.000) of ATP2B1 gene rs71454161, rs73196661 and rs73196675 were observed between disease group and control group. Furthermore, a high degree of linkage disequilibrium was detected between rs71454161 and rs73196661 (D'=0.329). The ATP2B1 gene rs73196675 polymorphism was evidently correlated with the gene expression of ATP2B1 (p<0.05), and the patients with genotype GG had a lower expression level of ATP2B1. The ATP2B1 gene rs71454161 was evidently correlated with the 24-h urinary protein in eclampsia patients (p=0.021), and the patients with genotype AG had a higher level of 24-h urinary proteins. The rs73196661 polymorphism was significantly correlated with LDH (p=0.000), and the patients with genotype CC had a higher level of LDH.
    Conclusions: The ATP2B1 gene polymorphism was significantly correlated with the occurrence and progression of eclampsia.
    MeSH term(s) Alleles ; Eclampsia/genetics ; Female ; Gene Frequency ; Genetic Predisposition to Disease ; Genotype ; Haplotypes ; Humans ; Plasma Membrane Calcium-Transporting ATPases/genetics ; Polymorphism, Genetic ; Polymorphism, Single Nucleotide ; Pregnancy
    Chemical Substances ATP2B1 protein, human ; Plasma Membrane Calcium-Transporting ATPases (EC 3.6.3.8)
    Language English
    Publishing date 2022-03-06
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 605550-3
    ISSN 2284-0729 ; 1128-3602 ; 0392-291X
    ISSN (online) 2284-0729
    ISSN 1128-3602 ; 0392-291X
    DOI 10.26355/eurrev_202202_28118
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top